{"id":"bucolome","rwe":[],"tags":[{"label":"bucolome","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"bucolom","offLabel":[],"synonyms":["1-cyclohexyl-5-butylbarbituric acid","bucolome","bucolom","paramidin","paramidine"],"timeline":[],"brandName":"Bucolom","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"bucolome","explanation":"Imagine your cells have a specific 'switch' that controls a certain process. Bucolome is believed to flip this switch, either turning it on or off, to help treat a particular condition. However, the exact details of how it interacts with this switch are still not fully understood.","oneSentence":"Bucolome is thought to work by interacting with a specific cellular pathway to produce a therapeutic effect.","technicalDetail":"Bucolome is a small molecule that binds to a specific protein or receptor, triggering a cascade of downstream effects that ultimately lead to its therapeutic outcome."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3044","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=BUCOLOME","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T09:07:35.496607","biosimilars":[],"competitors":[],"genericName":"bucolome","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"9T08RAL174","CHEBI":"CHEBI:31314","INN_ID":"2284","UMLSCUI":"C0006339","ChEMBL_ID":"CHEMBL2106136","KEGG_DRUG":"D01661","PUBCHEM_CID":"2461","MESH_SUPPLEMENTAL_RECORD_UI":"C084817"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":54,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Bucolome, a small molecule drug in the bucolome class, is a compound of unknown origin and current ownership. Its target and exact mechanism of action are also unknown. Bucolome's commercial status, including FDA approval and patent status, is unclear. Further research is needed to determine its approved indications, half-life, bioavailability, and generic manufacturers. As a result, key safety considerations and potential side effects are currently unknown.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}